Search Within

Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies

Journal: Current Diabetes Reviews
Volume: 12,Issue: 4
Page: 331-358
Authors: Karen Ekkelund Petersen, Günaj Rakipovski, Kirsten Raun and Jens Lykkesfeldt

Male fertility and obesity: are ghrelin, leptin and glucagon-like peptide-1 pharmacologically relevant?

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 7
Page: 783-791
Authors: Marco G. Alves, Tito T. Jesus, Mário Sousa, Erwin Goldberg, Branca M. Silva and Pedro F. Oliveira

Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and Efficacy

Journal: Current Diabetes Reviews
Volume: 12,Issue: 4
Page: 403-413
Authors: Scott R. Drab

Glucagon-Like Peptide-1-Mediated Modulation of Inflammatory Pathways in the Diabetic Brain: Relevance to Alzheimer’s Disease

Journal: Current Alzheimer Research
Volume: 13,Issue: 12
Page: 1346-1355
Authors: LiMei Qin, Thomas Chong, Richard Rodriguez and Subbiah Pugazhenthi

Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?

Journal: Current Vascular Pharmacology
Volume: 14,Issue: 6
Page: 494-497
Authors: Vasilios G. Athyros, Niki Katsiki and Asterios Karagiannis

Computational Identification of Inhibitors Against DPP-IV for Checking Type-2 Diabetes

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 1
Page: 66-73
Authors: Sarvesh Kumar Gupta, Kamal Kumar Chaudhary, Utkarsh Raj and Nidhi Mishra

Recent Advances in Synthetic Chemistry of Diabetic Research

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15,Issue: 14
Page: 1159-1163
Authors: Sreekanth Thota and Carlos M. Morel

Evaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma Diagnosis

Journal: Current Radiopharmaceuticals
Volume: 10,Issue: 1
Page: 65-72
Authors: Bluma Linkowski Faintuch, Daniele Seo, Erica Aparecida de Oliveira, Roselaine Campos Targino and Ana Maria Moro

GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 36
Page: 5292-5298
Authors: Djordje S. Popovic, Edita Stokic and Stevan L. Popovic

Novel Therapeutic Targets for Management of Type-2 Diabetes Mellitus

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 16,Issue: 1
Page: 18-30
Authors: Anishkumar Chaurasia, Rashmi Mallya and Tabassum Khan

Incretins, Pregnancy, and Gestational Diabetes

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 7
Page: 597-602
Authors: Dragana Nikolic, Khalid Al-Rasadi, Noor Al Busaidi, Khalid Al-Waili, Yajnavalka Banerjee, Khamis Al-Hashmi, Giuseppe Montalto, Ali A. Rizvi, Manfredi Rizzo and Tamima Al-Dughaishi

GPR 120: The Potential Target for Obesity Treatment

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 16,Issue: 1
Page: 8-11
Authors: Peter A. Tanagho and Kyrillus S. Shohdy

SGLT2 Inhibitors in Diabetes Mellitus Treatment

Journal: Reviews on Recent Clinical Trials
Volume: 12,Issue: 1
Page: 8-18
Authors: Juan Rosas-Guzman, Juan Rosas-Saucedo and Alma R.J. Romero-Garcia

How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 10
Page: 1242-1259
Authors: Robert Root-Bernstein

Previous     Next

Go To   Results 1 - 15 of 23